全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma in a 22-Year-Old Male

DOI: 10.4236/crcm.2025.142005, PP. 41-50

Keywords: Renal Cell Carcinoma, Metastatic, Retroperitoneal Mass, Tuberculosis, Primary Tumor

Full-Text   Cite this paper   Add to My Lib

Abstract:

Primary renal cell carcinoma (RCC) with metastasis is common with an estimated 30% of patients with RCC having metastases at the time of diagnosis. Evidence of metastatic RCC without a primary renal tumor is extremely rare with only a handful of cases citing this occurrence. Occasionally an unclear patient presentation requires thoughtful consideration of all the possibilities and results in a clinician reexamining the data to expand a differential, thus arriving at a diagnosis. This is the case of a 22-year-old who presented with diffuse lymphadenopathy, fever, cough, lower abdominal pain following a trip to India where the patient was hospitalized, initially believed to be tuberculosis. After multiple needle biopsies of lymph nodes and a retroperitoneal mass that were insufficient for a diagnosis, a wide excisional biopsy was performed that led to a diagnosis in our patient. The patient was diagnosed with metastatic TFE3-rearranged (MiT translocation) renal cell carcinoma and subsequently started on pembrolizumab and Lenvatinib followed by debulking surgery.

References

[1]  (2018) Kidney and Renal Pelvis Cancer—Cancer Stat Facts. SEER.
https://seer.cancer.gov/statfacts/html/kidrp.html
[2]  Wiechno, P., Kucharz, J., Sadowska, M., Michalski, W., Sikora-Kupis, B., Jonska-Gmyrek, J., et al. (2018) Contemporary Treatment of Metastatic Renal Cell Carcinoma. Medical Oncology, 35, Article No. 156.
https://doi.org/10.1007/s12032-018-1217-1
[3]  Padala, S.A., Barsouk, A., Thandra, K.C., Saginala, K., Mohammed, A., Vakiti, A., et al. (2020) Epidemiology of Renal Cell Carcinoma. World Journal of Oncology, 11, 79-87.
https://doi.org/10.14740/wjon1279
[4]  Bianchi, M., Sun, M., Jeldres, C., Shariat, S.F., Trinh, Q., Briganti, A., et al. (2012) Distribution of Metastatic Sites in Renal Cell Carcinoma: A Population-Based Analysis. Annals of Oncology, 23, 973-980.
https://doi.org/10.1093/annonc/mdr362
[5]  Kumar, R.M., Aziz, T., Jamshaid, H., Gill, J. and Kapoor, A. (2014) Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour. Current Oncology, 21, 521-524.
https://doi.org/10.3747/co.21.1914
[6]  Wayne, M., Wang, W., Bratcher, J., Cumani, B., Kasmin, F. and Cooperman, A. (2010) Renal Cell Cancer without a Renal Primary. World Journal of Surgical Oncology, 8, Article No. 18.
https://doi.org/10.1186/1477-7819-8-18
[7]  Hlaing, S.S., Desai, D., Goyal, A., Rai, N. and Swaab, R. (2022) Wandering Cancer Cells: Metastatic Renal Cell Carcinoma without Evidence of a Primary Tumor. Cureus, 14, e26305.
https://doi.org/10.7759/cureus.26305
[8]  Shields, L.B. and Kalebasty, A.R. (2020) Metastatic Clear Cell Renal Cell Carcinoma in Isolated Retroperitoneal Lymph Node without Evidence of Primary Tumor in Kidneys: A Case Report. World Journal of Clinical Oncology, 11, 103-109.
https://doi.org/10.5306/wjco.v11.i2.103
[9]  Ellati, R.T., Abukhiran, I., Alqasem, K., Jasser, J., Khzouz, J., Bisharat, T., et al. (2017) Clinicopathologic Features of Translocation Renal Cell Carcinoma. Clinical Genitourinary Cancer, 15, 112-116.
https://doi.org/10.1016/j.clgc.2016.05.013
[10]  Sun, G., Chen, J., Liang, J., Yin, X., Zhang, M., Yao, J., et al. (2021) Integrated Exome and RNA Sequencing of TFE3-Translocation Renal Cell Carcinoma. Nature Communications, 12, Article No. 5262.
https://doi.org/10.1038/s41467-021-25618-z
[11]  Zhu, Y., Han, C.H., Yang, Y.L., Xu, J.J. and Yu, Y.W. (2020) [Metastatic Renal Cell Carcinoma: A Clinicopathological Analysis of 196 Cases]. Chinese Journal of Pathology, 49, 1255-1260.
https://doi:10.3760/cma.j.cn112151-20200601-00437
[12]  Rastogi, R. (2008) Retroperitoneal Cystic Metastases from Renal Cell Carcinoma. Saudi Journal of Kidney Diseases and Transplantation, 19, 244-246.
[13]  Ishii, N., Yonese, J., Tsukamoto, T., Maezawa, T., Ishikawa, Y. and Fukui, I. (2001) Retroperitoneal Cystic Metastasis from a Small Clear Cell Renal Carcinoma. International Journal of Urology, 8, 637-639.
https://doi.org/10.1046/j.1442-2042.2001.00385.x
[14]  Ali, H.O., Ghorab, T., Cameron, I.R. and Marzouk, A.M. (2021) Renal Cell Carcinoma Metastasis to the Breast: A Rare Presentation. Case Reports in Radiology, 2021, Article ID: 6625689.
[15]  Cheng, S.K.H. and Chuah, K.L. (2016) Metastatic Renal Cell Carcinoma to the Pancreas: A Review. Archives of Pathology & Laboratory Medicine, 140, 598-602.
https://doi.org/10.5858/arpa.2015-0135-rs
[16]  Hsieh, S., Chung, S. and Chang, D. (2022) Metastatic Renal Cell Carcinoma of the Scalp: An Unusual Presentation. Asian Journal of Surgery, 45, 2566-2567.
https://doi.org/10.1016/j.asjsur.2022.05.156
[17]  Singla, A., Sharma, U., Makkar, A., Masood, P.F., Goel, H.K., Sood, R., et al. (2022) Rare Metastatic Sites of Renal Cell Carcinoma: A Case Series. Pan African Medical Journal, 42, Article 26.
https://doi.org/10.11604/pamj.2022.42.26.33578
[18]  Sukov, W.R., Hodge, J.C., Lohse, C.M., Leibovich, B.C., Thompson, R.H., Pearce, K.E., et al. (2012) TFE3 Rearrangements in Adult Renal Cell Carcinoma. American Journal of Surgical Pathology, 36, 663-670.
https://doi.org/10.1097/pas.0b013e31824dd972
[19]  Meyer, P.N., Clark, J.I., Flanigan, R.C. and Picken, M.M. (2007) Xp11.2 Translocation Renal Cell Carcinoma with Very Aggressive Course in Five Adults. American Journal of Clinical Pathology, 128, 70-79.
https://doi.org/10.1309/lr5g1vmxpy3g0cuk
[20]  Choueiri, T.K., Lim, Z.D., Hirsch, M.S., Tamboli, P., Jonasch, E., McDermott, D.F., et al. (2010) Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Adult Metastatic Xp11.2 Translocation Renal Cell Carcinoma. Cancer, 116, 5219-5225.
https://doi.org/10.1002/cncr.25512
[21]  Albiges, L., Gurney, H., Atduev, V., Suarez, C., Climent, M.A., Pook, D., et al. (2023) Pembrolizumab Plus Lenvatinib as First-Line Therapy for Advanced Non-Clear-Cell Renal Cell Carcinoma (KEYNOTE-B61): A Single-Arm, Multicentre, Phase 2 Trial. The Lancet Oncology, 24, 881-891.
https://doi.org/10.1016/s1470-2045(23)00276-0

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133